Analysis of Micronutrient Tests for Nutritional Deficiencies in Patients with Ehlers-Danlos Syndrome

Completed
Written By Amber Amburgey

PRINCIPAL INVESTIGATORS: Jessica Pizano DCN, Isabelle Brock MD, and Anne Maitland MD PhD, (NovaCombian Research Institute/Clinical Paradigms LLC, Chesterfield VA); Alissa Zingman MD, (P.R.I.S.M Spine and Joint), Clair A. Francomano MD (Indiana University School of Medicine); Jane R. Schubart PhD (Penn State College of Medicine)

PROJECT GOAL: Identify nutritional deficiencies in people with Ehlers-Danlos Syndromes (EDS) as a starting point for potential therapeutic targeting.

STUDY TYPE: Pilot study, retrospective chart analysis 

STATUS: Abstract presented at the American College of Medical Genetics, March 18, 2023

 SUMMARY: Hypersensitivity disorders, including mast cell activation disease (MCAD), are emerging as a recognized comorbidity with the hypermobile type of EDS. Nutritional testing is a promising approach to prescribe nutritional therapies to meet the precise needs of patients with EDS. Dietary interventions with higher doses of specific nutrients may be effective in managing symptoms in this population.

The results of this EDSRF study were presented at the annual meeting of the American College of Medical Genetics on March 18, 2023 in Chicago.

Read the Abstract.

Amber Amburgey
Previous

Prevalence of Ehlers Danlos Syndromes and Autonomic Dysfunction in Patients with Mannose Binding Lectin Deficiency
Next

Changes in Pain and Other Symptoms of Ehlers-Danlos Syndromes Over Time